Academisch Medisch Centrum - Universiteit van Amsterdam
OrganisationROR
Trials
The Effect of a Combined Lifestyle Intervention for Patients With Cancer on Quality of Life
CollaboratorNo phaseActive, not recruiting2025221 people8 Aug 2025clinicaltrials.gov
Phase 2Recruiting2026290 people2 Jun 2025clinicaltrials.gov
Phase 4Completed202260 people13 Feb 2025clinicaltrials.gov
CollaboratorPhase 4Not yet recruiting2025612 people21 Jan 2025clinicaltrials.gov
Phase 2Active, not recruiting2023110 people20 Jun 2024clinicaltrials.gov
Phase 3Recruiting2021158 people29 Sept 2023clinicaltrials.gov
Phase 4Completed202348 people15 Jun 2023clinicaltrials.gov
Phase 4Status unknown202322 people27 Oct 2022clinicaltrials.gov
Dasatinib and Quercetin to Treat Fibrotic Non-alcoholic Fatty Liver Disease
Phase 1/2Completed202330 people18 Aug 2022clinicaltrials.gov
CollaboratorPhase 4Status unknown202290 people13 Jul 2022clinicaltrials.gov
Phase 2Completed202212 people2 Jun 2022clinicaltrials.gov
Phase 4Status unknown20223,090 people18 Nov 2021clinicaltrials.gov
CollaboratorPhase 4Withdrawn20220 people13 Oct 2021clinicaltrials.gov
Phase 2Active, not recruiting202141 people18 Sept 2020clinicaltrials.gov
CollaboratorPhase 2/3Status unknown2021400 people9 Sept 2020clinicaltrials.gov
Phase 2Terminated20145 people9 Aug 2019clinicaltrials.gov
CollaboratorPhase 4Active, not recruiting2019374 people9 Jan 2019clinicaltrials.gov
CollaboratorPhase 3Active, not recruiting2019204 people26 Oct 2018clinicaltrials.gov
Phase 2Recruiting201949 people20 Dec 2017clinicaltrials.gov
Phase 2Completed20174 people30 Mar 2017clinicaltrials.gov